Cognate antigen engagement induces HIV-1 expression in latently infected CD4+ T cells from people on long-term antiretroviral therapy

Immunity. 2024 Dec 10;57(12):2928-2944.e6. doi: 10.1016/j.immuni.2024.11.002. Epub 2024 Nov 28.

Abstract

Despite antiretroviral therapy (ART), HIV-1 persists in latently infected CD4+ T cells, preventing a cure. Antigens drive the proliferation of infected cells, precluding latent reservoir decay. However, the relationship between antigen recognition and HIV-1 gene expression is poorly understood because most studies of latency reversal use agents that induce non-specific global T cell activation. Here, we isolated rare CD4+ T cells responding to cytomegalovirus (CMV) or HIV-1 Gag antigens from people living with HIV-1 on long-term ART and assessed T cell activation and HIV-1 RNA expression upon coculture with autologous dendritic cells (DCs) presenting cognate antigens. Presentation of cognate antigens ex vivo induced broad T cell activation (median 42-fold increase in CD154+CD69+ cells) and significantly increased HIV-1 transcription (median 4-fold), mostly through the induction of rare cells with higher viral expression. Thus, despite low proviral inducibility, antigen recognition can promote HIV-1 expression, potentially contributing to spontaneous reservoir activity and viral rebound upon ART interruption.

Keywords: CD4(+) T cells; HIV-1 latent reservoir; HIV-1 persistence; antigenic stimulation; cytomegalovirus; dendritic cells; latency reversal.

MeSH terms

  • Adult
  • Anti-Retroviral Agents / pharmacology
  • Anti-Retroviral Agents / therapeutic use
  • Antigens, Viral / immunology
  • CD4-Positive T-Lymphocytes* / immunology
  • Cytomegalovirus / immunology
  • Dendritic Cells* / immunology
  • Female
  • Gene Expression Regulation, Viral
  • HIV Infections* / drug therapy
  • HIV Infections* / immunology
  • HIV Infections* / virology
  • HIV-1* / immunology
  • Humans
  • Lymphocyte Activation* / immunology
  • Male
  • Middle Aged
  • Virus Latency* / drug effects
  • Virus Latency* / immunology
  • gag Gene Products, Human Immunodeficiency Virus / immunology

Substances

  • Antigens, Viral
  • Anti-Retroviral Agents
  • gag Gene Products, Human Immunodeficiency Virus